Literature DB >> 12616975

Levels of haemostatic factors, arteriosclerosis and cardiovascular disease.

F Haverkate1.   

Abstract

Plasma levels of haemostasis factors (HFs) such as fibrinogen, tissue-type plasminogen activator (t-PA), plasminogen activator inhibitor-1 (PAI-1) and D-dimer may be markers of arteriosclerosis for the following reasons: There seems to be no difference in levels of HFs between patients with longstanding stable angina and those with an isolated myocardial infarction. HF levels are generally positively associated with subclinical arteriosclerosis as determined by ankle-arm index and carotid ultrasonography in asymptomatic individuals. Levels of most HFs are positively associated with inflammation, which is an essential part of the initiation and progression of the disease. A rough classification is assigned to the associations found in under (2) and (3). Fibrinogen is strongly associated with subclinical arteriosclerosis and with inflammation; Factor VII is not, while an intermediate group is formed by, for instance, von Willebrand Factor (vWF), Factor VIII (F VIII), t-PA, PAI-1, and D-dimer. Also, the associations of HFs with cardiovascular events follow a similar pattern. Fibrinogen is a strong and consistent risk factor in several studies, Factor VII is not, and a similar intermediate group as mentioned under (2) and (3) exists. It suggests that the risk of cardiovascular events in relation to HF levels is explained by their identity as markers of arteriosclerosis. A causal association between HF levels and the disease is not proven. Out of the HF, the markers of coagulation such as thrombin-antithrombin complex and of fibrinolysis such as D-dimer are more likely to act causally. Increased levels indicate that they are markers of arteriosclerosis, but in addition, they may reflect a low-grade, continuous formation and subsequent lysis of fibrin in the disease. As the latter reflects an increased tendency to thrombosis, a causal association of levels of markers of coagulation and fibrinolysis with arteriosclerosis, although not yet proven, seems likely.

Entities:  

Mesh:

Year:  2002        PMID: 12616975     DOI: 10.1016/s1537-1891(02)00295-1

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  8 in total

1.  Regulation of Hemostasis by the Sympathetic Nervous System: Any Contribution to Coronary Artery Disease?

Authors:  Daniel Preckel; Roland von Känel
Journal:  Heartdrug       Date:  2004

2.  Leptin down-regulates peroxisome proliferator-activated receptor gamma (PPAR-gamma) mRNA levels in primary human monocyte-derived macrophages.

Authors:  Agatha Cabrero; Marta Cubero; Gemma Llaverías; Marta Alegret; Rosa Sánchez; Juan Carlos Laguna; Manuel Vázquez-Carrera
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

3.  Evaluation of various endothelial biomarkers in ankylosing spondylitis.

Authors:  Ali Taylan; Ismail Sari; Didem L Kozaci; Yasar Yildiz; Safak Bilge; Isil Coker; Sergir Maltas; Necati Gunay; Nurullah Akkoc
Journal:  Clin Rheumatol       Date:  2011-05-10       Impact factor: 2.980

4.  Short-term chamber exposure to low doses of two kinds of wood smoke does not induce systemic inflammation, coagulation or oxidative stress in healthy humans.

Authors:  Leo Stockfelt; Gerd Sallsten; Pernilla Almerud; Samar Basu; Lars Barregard
Journal:  Inhal Toxicol       Date:  2013-07-01       Impact factor: 2.724

Review 5.  Function and Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis.

Authors:  Feifei Li; Xia Guo; Shi-You Chen
Journal:  Front Cardiovasc Med       Date:  2017-05-22

6.  Inflammatory and coagulatory markers and exposure to different size fractions of particle mass, number and surface area air concentrations in Swedish iron foundries, in particular respirable quartz.

Authors:  Håkan Westberg; Alexander Hedbrant; Alexander Persson; Ing-Liss Bryngelsson; Anders Johansson; Annette Ericsson; Bengt Sjögren; Leo Stockfelt; Eva Särndahl; Lena Andersson
Journal:  Int Arch Occup Environ Health       Date:  2019-06-04       Impact factor: 3.015

Review 7.  Serpins in thrombosis, hemostasis and fibrinolysis.

Authors:  J C Rau; L M Beaulieu; J A Huntington; F C Church
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

Review 8.  The Role of Mesenchymal Stem Cells in Atherosclerosis: Prospects for Therapy via the Modulation of Inflammatory Milieu.

Authors:  Armita Mahdavi Gorabi; Maciej Banach; Željko Reiner; Matteo Pirro; Saeideh Hajighasemi; Thomas P Johnston; Amirhossein Sahebkar
Journal:  J Clin Med       Date:  2019-09-08       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.